|
| | Publication Year | Title | Author(s) |
| 1 | Nov-2016 | High circulating oestrone and low testosterone correlate with adverse clinical outcomes in men with advanced liver disease. | Sinclair, Marie ; Gow, Paul J ; Angus, Peter W ; Hoermann, Rudolf; Handelsman, David J; Wittert, Gary; Martin, Sean; Grossmann, Mathis |
| 2 | Nov-2016 | Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the MELD score | Sinclair, Marie ; Gow, Paul J ; Grossmann, Mathis ; Shannon, Adam; Hoermann, Rudolf; Angus, Peter W |
| 3 | Mar-2016 | Low testosterone as a better predictor of mortality than sarcopenia in men with advanced liver disease. | Sinclair, Marie ; Grossmann, Mathis ; Angus, Peter W ; Hoermann, Rudolf; Hey, Penelope ; Scodellaro, Thomas ; Gow, Paul J |
| 4 | 15-Oct-2014 | Low-serum testosterone levels pre-liver transplantation are associated with reduced rates of early acute allograft rejection in men. | Sinclair, Marie ; Angus, Peter W ; Gow, Paul J ; Hoermann, Rudolf; Mogilevski, Tamara; Grossmann, Mathis |
| 5 | 27-Jan-2014 | Muscle mass and mortality in chronic liver disease: the impact of testosterone. | Sinclair, Marie ; Angus, Peter W ; Grossmann, Mathis ; Gow, Paul J |
| 6 | Apr-2016 | Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions | Sinclair, Marie ; Gow, Paul J ; Grossmann, Mathis ; Angus, Peter W |
| 7 | 1-Feb-2015 | Testosterone in men with advanced liver disease: abnormalities and implications. | Sinclair, Marie ; Grossmann, Mathis ; Gow, Paul J ; Angus, Peter W |
| 8 | Nov-2016 | Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial | Sinclair, Marie ; Grossmann, Mathis ; Hoermann, Rudolf; Angus, Peter W ; Gow, Paul J |
